SGLT2 Inhibitors and Renal Anemia in Japan: RWD

Clinical trial NCT07063316 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07063316
Sponsor: Boehringer Ingelheim
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Chronic Kidney Disease

Start date: 2025-07-23
Primary completion: 2026-12-25
Enrollment: 15000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.